| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ANI PHARMACEUTICALS INC COM | 320,000 | 14,440,000 | 23.89% | ||
| 2 | Albany Molecular | 402,400 | 7,988,000 | 13.21% | ||
| 3 | QLT INC | 2,157,200 | 5,738,000 | 9.49% | ||
| 4 | PFIZER INC | 150,000 | 4,842,000 | 8.01% | ||
| 5 | QUEST DIAGNOSTICS INC | 66,208 | 4,710,000 | 7.79% | ||
| 6 | CRYOLIFE INC | 370,000 | 3,989,000 | 6.60% | ||
| 7 | DEPOMED INC | 200,000 | 3,626,000 | 6.00% | ||
| 8 | ALLERGAN PLC | 10,000 | 3,125,000 | 5.17% | ||
| 9 | GLAXOSMITHKLINE PLC | 50,000 | 2,018,000 | 3.34% | Call | |
| 10 | PROSHARES ULTRASHORT RUSSELL2000 | 50,000 | 1,965,000 | 3.25% | Call | |
| 11 | PROSHARES ULTRASHORT RUSSELL2000 | 50,000 | 1,965,000 | 3.25% | ||
| 12 | ANI PHARMACEUTICALS INC COM | 25,000 | 1,128,000 | 1.87% | Call | |
| 13 | CYTOKINETICS INC | 100,000 | 1,046,000 | 1.73% | ||
| 14 | AMARIN CORP PLC | 400,000 | 756,000 | 1.25% | Call | |
| 15 | MANNKIND CORPORATION | 500,000 | 725,000 | 1.20% | Put | |
| 16 | FIBROCELL SCIENCE INC | 147,769 | 672,000 | 1.11% | ||
| 17 | ZOGENIX INC | 31,850 | 469,000 | 0.78% | ||
| 18 | PERNIX THERAPEUTICS HLDGS IN | 150,000 | 443,000 | 0.73% | ||
| 19 | SORRENTO THERAPEUTICS INC COM NEW | 50,000 | 436,000 | 0.72% | ||
| 20 | Apricus Biosciences, Inc. | 140,000 | 139,000 | 0.23% | ||
| 21 | Sunesis Pharmaceuticals I | 150,000 | 135,000 | 0.22% | Call | |
| 22 | Apricus Biosciences, Inc. | 100,000 | 99,000 | 0.16% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-16-011065, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
